Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma

Figure 14

Correlation analysis of prognostic signature with TMB. (a) The mutational landscape between high- and low-risk groups. (b) Differences in the levels of TMB between high- and low-risk groups. (c) Differences in Kaplan–Meier survival between high and low levels of TMB. (d) Differences in Kaplan–Meier survival between subgroups stratified by H−TMB + high risk, H−TMB + low risk, L−TMB + high risk, and L−TMB + low risk. TMB: tumor mutation burden.

(a)

(b)

(c)

(d)